Table 3. Correlations between AMH serum level and pre/post treatment features.
N° patients | ρ | p | |
aAge | 46 | −0,224 | 0,134 |
aBasal LH | 46 | −0,038 | 0,808 |
aBasal estradiol | 46 | −0,093 | 0,623 |
a Basal FSH | 46 | −0,400 | 0,007 |
bTotal dose of administered FSH (IU) | 44 | −0,285 | 0,064 |
c Follicles on day of HCG | 44 | 0,662 | <0,001 |
c Estradiol on day of HCG | 44 | 0,548 | <0,001 |
c Collected oocytes | 41 | 0,643 | <0,001 |
d Fertilized oocytes | 41 | 0,400 | 0,009 |
dObtained embryos | 41 | 0,294 | 0,062 |
dTransferred embryos | 41 | 0,289 | 0,067 |
Notes:
Correlation between AMH and pre-treatment features of patients;
Correlation between AMH and total dose of administered FSH;
Correlation between AMH and ovarian response;
Correlation between AMH and reproductive outcome.